期刊文献+

基于体内过程的中药毒性成分和毒性效应物质的发现策略 被引量:34

Discovery Strategy for Toxic-invited Constituents and Toxic-effective Substances on Chinese Material Medica Based on Processes of Metabolism and Disposition in Intra-body
下载PDF
导出
摘要 中药是在中医药理论指导下使用的药物,其来源以植物药为主,其次是动物药、矿物药,还有小部分是化学药和生物制品。由于中药生物来源、生态环境、化学物质结构、炮制方法、代谢途径和代谢产物的多样性以及生物活性和临床应用的多样性,构成了一个庞大的复杂系统,蕴涵着许多科学问题。解析这个复杂系统的基础科学问题之一是毒性成分和毒性效应物质的阐明。伴随中药代谢的研究进展和新兴学科代谢组学的出现,形成了“基于体内过程的中药毒性成分和毒性效应物质的发现策略”,其将为中药复杂体系的研究提供新的方法和途径。 Chinese material medica is the natural therapeutic agent used under the guidance of the theories of traditional Chinese medicine. Its sources are mainly derived from plants, some derived from animals and minerals, and a few derived from chemical drugs and biologic products. It was made up into a colossal complex system because of its diversity of biological sources, ecological environments, chemical constituent structures, processing methods, processes of metabolian-disposition and their products in intra-body, biological activity and clinical use, and involved a lot of scientific problems. The elucidation of the toxic-invited constituents and toxic-effective substances is one of basic and scientific problem to clarify complex system of Chinese material medica. Along with the research progress of processes of metabolism and disposition of Chinese material medica in intra-body and metabonomics, a new and rapid-developing technology, the discovery strategy for toxic-invited constituents and toxic-effective substances on Chinese material medica based on the processes of metabolism and disposition would be made up, which will provide a new methodology and pathway to clarify of complex system of Chinese material medica.
作者 杨秀伟
机构地区 北京大学药学院
出处 《中华中医药杂志》 CAS CSCD 北大核心 2007年第2期67-72,共6页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家高技术领域研究计划"863"资助项目(No.2002AA2Z343C) 北京市科技专项资助项目(No.Z0004105040311)
关键词 中药体内过程 毒性成分 毒性效应物质 发现策略 processes of metabolism and disposition on Chinese material medica in intra-body toxic-invited constituents toxic-effective substances discovery strategy
  • 相关文献

参考文献23

  • 1杨秀伟.药学前沿(2003年卷).北京:中国医药科技出版社,2004:396-447
  • 2Zhou S,Koh H L,Gao Y,et al.Herbal bioactivation:The good,the bad and the ugly.Life Sci,2004,74 (8):935 -968
  • 3Mengs U,Stotzem C D.Renal toxicity of aristolochic acid in rats as an example of nephrotoxi-city testing in routing toxicity.Arch Toxicol,1993,67:307-311
  • 4Mengs U,Stotzem C D.Toxicity of aristolochic acid-a subacute study in male rats.Med Sci Res,1992,20:223-224
  • 5崔太根,王海燕,尚明英,蔡少青,邹万忠.药典法定剂量关木通对大鼠肾功能及间质结构影响的研究[J].中华肾脏病杂志,2000,16(2):106-109. 被引量:88
  • 6张卫华.三种木通利尿作用及其毒性的比较研究[J].中国药学杂志,1989,24(10):594-596. 被引量:46
  • 7叶志斌,许静,梅小斌,陆国才,王忠壮.长期小剂量应用关木通对部分肾切除大鼠肾脏的影响[J].中国中西医结合杂志,2002,22(6):447-449. 被引量:5
  • 8Arlt V M,Stiborova M,Schmeiser H H.Aristolochic acid as a probable human cancer hazard in herbal remedies:a review.Mutagenesis,2002,17 (4):265-277
  • 9Stiborova M,Frei E,Breuer A,et al.Aristolactam Ⅰa metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.Exp Toxicol Pathol,1999,51(4-5):421 -427
  • 10Arlt V M,Wiessler M,Schmeiser H H.Using polymerase arrest to detect DNA binding speci-ficity of aristolochic acid in the mouse H-ras gene.Carcinogenesis,2000,21 (2):235-242

二级参考文献6

共引文献126

同被引文献389

引证文献34

二级引证文献483

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部